Cannabis is a family of plants with two primary classifications, Indica and Sativa. Despite the two falling under one cannabis family, they are widely different in their biological makeup and effects. Although marijuana can fall into either family, marijuana is linked to having psychoactive effects on the user because of its tetrahydrocannabinol or THC component-heavy makeup. On the other hand, hemp does not provide psychoactive effects because of its main component, cannabidiol or CBD and while marijuana can contain anywhere from 15% to 40% of THC concentration, hemp normally contains less than 0.3%. In fact, it is the heavy THC concentration within marijuana which caused international organizations to put restrictions on the plant, making it one of the most enforced drugs worldwide. However, due to ongoing research and studies, positive results are leading countries to reconsider the cannabis plant. In particular, most countries are looking to adopt a cannabis legislation for medical applications, but countries like the U.S. and Canada have already established a large recreational user base. Overall, the combination of the accelerating recreational and medical sectors is set to caus the greater cannabis industry to witness sizeable growth in the near future. According to data compiled by Grand View Research, the global legal marijuana market is expected to reach USD 146.4 Billion by 2025, exhibiting a CAGR of 34.6%. Chineseinvestors.com Inc. (OTC: CIIX), Aphria Inc. (NYSE: APHA) (TSX: APHA), New Age Beverages Corporation (NASDAQ: NBEV), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), The Alkaline Water Company Inc. (NASDAQ: WTER) (TSX-V: WTER).
The medical market accounts for the largest share of the overall cannabis industry, but the U.S. and Canada are expected to gradually shift the market from medical to recreational. Currently, the recreational market has a very limited geographic reach due to legality matters, when compared to the medical sector. While the two markets are perceived very differently, one cannabis-based product is still thriving in both: CBD. In the recreational sector, consumers are using CBD products to simply relax, while medically, consumers are using it to treat sleep disorders and depression. Specifically, within the CBD marketplace, CBD hemp oil accounts for the largest share of the market because of its healthcare associated benefits. According to data compiled by Transparency Market Research, the global CBD hemp oil market was valued at USD 950 Million in 2017 and is expected to surpass USD 2.5 Billion by 2026. Additionally, the market is also expected to register a CAGR of 11% from 2018 to 2026. CBD oil is mainly being used for medical applications, but the increasing usage of oil in forms of spray, vape, and tinctures is expected to propel the entire industry. “It actually doesn’t produce any psychoactive effects, that’s why it’s actually legal and people don’t have to worry about abusing it or passing a drug test, or having any type of side effects,” said Alleyah Miner of AltPharm in Camp Springs. “I think it’s great to be us and bring it to the market because cbd has a lot of health benefits anti-inflammation for depression for stress pain relief.”
Chineseinvestors.com Inc. (OTCQB: CIIX) earlier this week announced breaking news that, “it will add a high-end, luxury brand of full spectrum CBD oil to its product offerings.
ChineseHempOil.com, Inc.’s new product was launched on March 9, 2019, at San Francisco’s KTSF-hosted Financial Carnival Event. The launch has proven successful, with sales exceeding $10,000 on the first day. Based on the initial reception and the price point for this top of the line CBD oil, the Company expects that this new addition should have a positive impact on revenues and should increase margins.
“Since the beginning of 2019, ChineseInvestors.com, Inc., and its wholly owned subsidiary ChineseHempOil.com, Inc., have been on the lookout for innovative CBD products for the global Chinese market,” stated Warren Wang, Chief Executive Officer of ChineseInvestors.com. “This 100% organic product, free of pesticides, herbicides, and chemical fertilizers, will provide our most discerning, health conscious customers with one of the highest quality CBD oils available.”
Products are available for purchase on the Company’s new platform, www.365cwc.com, which caters to both Chinese and English-speakers and offers a wide selection of wellness products, including:
OPT Hemp: Products include organic industrial hemp-derived CBD oil, CBD scrub and cream, with additional hemp-infused cosmetics and other industrial hemp-derived CBD products in the works.
OPT2Mist: A ground-breaking nutritional spray product line including a wide array of daily vitamin sprays, and full-spectrum CBD-infused sprays.
Our latest organic full spectrum CBD oil: A high-grade, organic, full spectrum hemp oil sourced from Colorado and free of pesticides, herbicides, and chemical fertilizers.
Dedicated to spreading awareness about the benefits of CBD, ChineseHempOil.com has been operating in the United States since 2017. Equipped with its strong reputation and its popular product lines, ChineseHempOil.com is constantly developing new and innovative ways to promote wellness in the Chinese community.